Skip nav

Re:Cognition Health is changing the future for those with memory loss and other symptoms of cognitive impairment, through providing education, clinical excellence and access to the most advanced treatments available worldwide.

It is an exciting time for research into Alzheimer’s disease and other causes of mild cognitive impairment (MCI) and dementia. Results from clinical trials are always encouraging, bringing us ever closer to treatments to slow or, ideally, halt the progression of the disease and to improve its symptoms.

Involvement in clinical trials enables individuals to receive the next generation of emerging medications, free of charge, before these medications are licensed for global use. Participants receive outstanding medical care and are monitored regularly throughout the study by a team of cognitive experts. All medical costs are covered by the pharmaceutical company.

Clinical trials are essential for advancing our...

Read full release